Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

LOGIN HERE

Cancel

BSE Code : 542919 | NSE Symbol : ARTEMISMED | ISIN : INE025R01021 | Industry : Healthcare |

Board Meeting

Announcement Date	Date Of Meeting	Purpose	Detail
30-Jan-2025	05-Feb-2025	Quarterly Results	Artemis Medicare Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/02/2025 inter alia to consider and approve the Un-audited Financial Results (Standalone & Consolidated) for the quarter/ nine months period ended December 31 2024. Outcome of Board Meeting held on February 5, 2025 (As Per BSE Announcement Dated on: 05/02/2025)
06-Nov-2024	14-Nov-2024	Quarterly Results	Artemis Medicare Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2024 inter alia to consider and approve the Un-audited Financial Results (Standalone & Consolidated) for the quarter/ half year ended September 30 2024. Outcome of Board Meeting held on November 14, 2024 (As Per BSE Announcement Dated on: 14/11/2024)
01-Aug-2024	08-Aug-2024	Quarterly Results	Artemis Medicare Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/08/2024 inter alia to consider and approve the Un-audited Financial Results (Standalone & Consolidated) for the quarter ended June 30 2024 Outcome of Board Meeting held on August 8, 2024 (As per BSE Announcement Dated on 08/08/2024)
03-May-2024	10-May-2024	Accounts	Artemis Medicare Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/05/2024 inter alia to consider and approve Audited Financial Results and Recommendation of Dividend if any. The Board of Directors at its meeting held on May 10, 2024 recommended divided of Re. 0.45 per share for FY24 Outcome of Board Meeting held on May 10, 2024 Audited Financial Results (Standalone and Consolidated) of the Company for the Quarter and Year Ended March 31, 2024 (As per BSE Announcement Dated on 10/05/2024)
02-Apr-2024	05-Apr-2024	Raising funds through Debt Instr.	Artemis Medicare Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/04/2024 inter alia to consider and approve the proposal for raising of funds by way of means permissible under applicable laws such as issue of equity shares/ convertible bonds/ debentures/ warrants/ preference shares/ any other equity linked securities and/ or any other securities including through preferential issue on a private placement basis qualified institutional placement rights issue or any other methods or combinations thereof Outcome of the Board Meeting-April 5, 2024 (As Per BSE Announcement Dated on 05/04/2024)
29-Jan-2024	05-Feb-2024	Quarterly Results	Artemis Medicare Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/02/2024 inter alia to consider and approve In pursuance of Regulation 29 and 33 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015 we wish to inform you that the meeting of the Board of Directors of the Company will be held on February 5 2024 (Monday) inter-alia to consider and approve the Un-audited Financial Results (Standalone & Consolidated) for the quarter/nine months period ended December 31 2023. As informed by our communication dated December 27 2023 the trading window for dealing in securities of the Company was closed from January 1 2024 and shall remain closed till 48 hours after declaration of financial results i.e. up to February 7 2024 (both days inclusive). Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations'), we wish to inform you that the Board of Directors at its meeting held today i.e. February 5, 2024, inter alia, considered and approved the Un-audited Financial Results (Standalone and Consolidated) of the Company for the quarter/nine months period ended December 31, 2023. (As Per BSE Announcement dated on 05.02.2024)
01-Nov-2023	08-Nov-2023	Quarterly Results	Artemis Medicare Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2023 inter alia to consider and approve In pursuance of Regulation 29 and 33 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015 we wish to inform you that the meeting of the Board of Directors of the Company will be held on November 8 2023 (Wednesday) inter-alia to consider and approve the Un-audited Financial Results (Standalone & Consolidated) for the quarter/half year ended September 30 2023. As informed by our communication dated September 29 2023 the trading window for dealing in securities of the Company was closed from October 1 2023 and shall remain closed till 48 hours after the declaration of financial results i.e. up to November 10 2023 (both days inclusive). Outcome of the board meeting Intimation attached (As per BSE Announcement Dated on 08/11/2023) Intimation attached (As Per BSE Announcement Dated on 09/11/2023)
31-Jul-2023	08-Aug-2023	Quarterly Results	Artemis Medicare Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/08/2023 inter alia to consider and approve In pursuance of Regulation 29 and 33 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015 we wish to inform you that the meeting of the Board of Directors of the Company will be held on August 8 2023 (Tuesday) inter-alia to consider and approve the Un-audited Financial Results (Standalone & Consolidated) for the quarter ended June 30 2023. As informed by our communication dated June 29 2023 the trading window for dealing in securities of the Company was closed from July 1 2023 and shall remain closed till 48 hours after the declaration of financial results i.e. up to August 10 2023 (both days inclusive). Outcome of Board Meeting held on August 8, 2023-quarterly financial result. Intimation attached Intimation attached (As Per BSE Announcement dated on 08.08.2023)
28-Apr-2023	05-May-2023	Accounts	Artemis Medicare Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/05/2023 inter alia to consider and approve Board Meeting to consider inter-alia Audited Financial Results and Declaration of Dividend if any. Pursuant to Reg 30 of SEBI Listing Regulations, we wish to inform you that Board of Directors at its meeting held today i.e. 5.5.2023, inter alia, considered and approved following: (a) Audited Financial Results (Standalone & Consolidated) of Company for the quarter and year ended 31.03.2023; (b) Recommended the Final dividend of Re. 0.45 per Equity Share of face value of Re. 1 each (i.e. 45%) for FY23, subject to the approval of shareholders at ensuing AGM, which shall be paid/dispatched on or before 30 days from conclusion of AGM; and (c) Re-appointment of Mr. Sanjib Sen as an Independent Director for a further period of 3 years with effect from 3.8.2023 subject to approval of Shareholders. The meeting of Board of Directors commenced at 4:30 PM and concluded at 6:15 PM. Please refer attached document for detailed information. (As Per BSE Bulletin Dated on 04.05.2023)
25-Jan-2023	01-Feb-2023	Quarterly Results	Artemis Medicare Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/02/2023 inter alia to consider and approve In pursuance of Regulation 29 and 33 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015 we wish to inform you that the meeting of the Board of Directors of the Company will be held on February 1 2023 (Wednesday) inter-alia to consider and approve the Un-audited Financial Results (Standalone & Consolidated) for the quarter/nine months period ended December 31 2022. As informed by our communication dated December 30 2022 the trading window for dealing in securities of the Company was closed from January 1 2023 and shall remain closed till 48 hours after the declaration of financial results i.e. up to February 3 2023 (both days inclusive). Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, ('Listing Regulations'), we wish to inform you that the Board of Directors at its meeting held today i.e. February 1, 2023, have inter-alia, considered and approved the following: 1. Un-audited Financial Results (standalone and consolidated) of the Company for the quarter/nine months period ended December 31, 2022. 2. Remuneration of Dr. Devlina Chakravarty (DIN:07107875), Managing Director for remaining period of 2 (two) years (of her term of 5 years as Managing Director), effective from April 1, 2023 to March 31, 2025 subject to approval of the shareholders by way of postal ballot. Pursuant to Regulation 33 of the Listing Regulations, please find enclosed herewith Un-audited financial results (standalone and consolidated) for the quarter/nine months period ended December 31, 2022 and limited review reports for the said period issued by the Statutory Auditors of the Company. (As per BSE Announcement Dated on 01/02/2023)
02-Nov-2022	09-Nov-2022	Quarterly Results	Artemis Medicare Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2022 inter alia to consider and approve the unaudited financial results for quarter & six months ended 30th September 2022. Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, ('Listing Regulations'), we wish to inform you that the Board of Directors at its meeting held today i.e. November 9, 2022, have inter-alia, considered and approved the following: a. Un-audited Financial Results (standalone and consolidated) of the Company for the quarter and half year ended September 30, 2022. b. Appointment of Ms. Poonam Makkar as the Company Secretary & Compliance Officer and Key Managerial Personnel of the Company with effect from November 09, 2022. We wish to inform you about the Appointment of Ms. Poonam Makkar as the Company Secretary & Compliance Officer and Key Managerial Personnel of the Company with effect from November 09, 2022. (As Per BSE Announcement Dated on 09/11/2022)
03-Aug-2022	11-Aug-2022	Quarterly Results	Artemis Medicare Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2022 inter alia to consider and approve the unaudited quarterly financial results for quarter ended 30th June 2022. The Artemis Medicare Services Limited has informed to stock exchange of newspaper publication of unaudited financial results for the quarter ended June 30, 2022. (As Per BSE Announcement Dated on 13/08/2022) Artemis Medicare Services Limited has informed the Exchange about Board Meeting held on 11-Aug-2022 to consider & Approve financial results for the quarter ended June 30, 2022. (As Per BSE Announcement Dated 11.08.2022)
02-May-2022	11-May-2022	Accounts	Audited Results & Quarterly Results Artemis Medicare Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/05/2022 ,inter alia, to consider and approve Intimation about the Board Meeting Outcome of the Board Meeting held today Financial Results for the FY 2021-22 (As Per BSE Announcement dated on 11.05.2022) Intimation Regarding Appointment Of Secretarial Auditor Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulation, 2015. (As per BSE Announcement Dated on 12/5/2022) Newspaper publication of Financial results (As Per BSE Announcement dated on 14.05.2022)
25-Jan-2022	01-Feb-2022	Quarterly Results	Artemis Medicare Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/02/2022 inter alia to consider and approve Approval of Un-Audited Financial results for the quarter and nine months ended 31st December 2021 Outcome of the Board Meeting held on 01 Feb 2022 (As Per BSE Announcement Dated on 01/02/2022)
19-Oct-2021	26-Oct-2021	Quarterly Results	Quarterly Results Artemis Medicare Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/10/2021 ,inter alia, to consider and approve Artemis Medicare Services Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/10/2021 ,inter alia, to consider and approve the Quarterly Financial Results of the company. Outcome of the Board Meeting Un-audited Financial results for quarter and half year ended on 30th september 2021 (As per BSE Announcement Dated on 26/10/2021)

1 2

LOGIN HERE

Artemis Medicare Services Ltd

Board Meeting